MACKENZIE FINANCIAL CORP
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 919859
TORONTO ONTARIO, A6
Position in VRTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$51,127,425
+$7,942,989 QoQ
Shares Held
102,928
+6.4% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#169
of 1,732 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MACKENZIE FINANCIAL CORP holds $498,673,295 across 59 Biotechnology names. VRTX ranks #4 (10.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
135,783 | $84,666,131 | |
| 2 | INCY |
Incyte Corp
|
634,862 | $71,967,956 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
931,864 | $53,321,258 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
102,928 | $51,127,425 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
298,440 | $22,227,811 | |
| 6 | TBPH |
Theravance Biopharma, Inc.
|
985,848 | $16,759,416 | |
| 7 | RPRX |
Royalty Pharma plc
|
270,457 | $15,164,523 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
43,988 | $13,241,707 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $51,127,425 | 102,928 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $43,184,436 | 96,709 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $28,697,234 | 63,299 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $21,282,892 | 54,343 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $16,149,630 | 36,275 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $17,485,518 | 36,066 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $18,376,006 | 45,632 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | $31,947,275 | 68,692 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $39,669,648 | 84,634 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $38,645,860 | 92,452 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $35,329,038 | 86,827 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $28,852,335 | 82,971 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $32,618,537 | 92,690 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $66,505,920 | 211,083 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $31,448,719 | 108,902 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $34,201,043 | 118,122 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $25,372,935 | 90,042 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $25,920,845 | 99,325 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $19,203,800 | 87,449 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $15,518,458 | 85,553 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $16,342,111 | 81,050 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $15,090,220 | 70,223 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $8,938,615 | 37,821 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $6,635,918 | 24,386 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $5,024,104 | 17,306 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,249,579 | 9,454 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||